The Dysmenorrhea Treatment Gap:
Gynecologists Insights Report 2026
Dysmenorrhea is not a benign complaint.
For most gynecologists, it is a high-frequency, high-impact condition that represents a recurring clinical burden, accounting for more than half of all patient visits for nearly 1 in 3 providers. We surveyed 100 gynecologists to understand why, despite its prevalence, this condition remains materially underserved by current standards of care.
Our latest report explores why dysmenorrhea remains a persistent clinical burden and why patients are increasingly looking beyond the traditional toolkit.
Inside the Report:
The Clinical Reality: Why gynecologists suspect or diagnose underlying pathology in at least 30% of cases, necessitating management beyond short-term relief
The Tolerance Gap: Why 59% of gynecologists describe the patient response to NSAIDs as neutral, revealing the difference between clinical effectiveness and true patient satisfaction.
The Hormonal Hurdle: An analysis of why high-efficacy hormonal treatments are often met with non-adherence due to concerns over hormonal side effects
The Demand for Innovation: 7 in 10 clinicians receive 10+ patient-initiated requests per week for new, non-hormonal solutions